Complicated Skin And Skin Structure Infection — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for complicated skin and skin structure infection. 16 active patents protecting 3 drugs from 3+ originators. First major cliff: 2031. Daily refresh.

3
Approved drugs
16
Active US patents
44/100
Avg vulnerability
—
Annual revenue covered

Originators in Complicated Skin And Skin Structure Infection

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Pfizer 10 patents Fresenius Kabi 4 patents Cumberland 2 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating complicated skin and skin structure infection. Each bar = one year. Y-axis scaled to peak year (7 patents).

2
27
1
28
1
29
1
30
7
31
1
33
1
38
2
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Merrem
Meropenem
 Pfizer 10 57 — 2031-08-08
Tygacil
TIGECYCLINE
 Fresenius Kabi 4 49 — 2028-10-24
Vibativ
TELAVANCIN HYDROCHLORIDE
 Cumberland 2 27 — 2027-01-01

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12478606 Merrem method of use 75 2038-01-08
12533342 Merrem method of use 75 2039-05-20
11376237 Merrem method of use 70 2039-04-06
11007206 Merrem method of use 68 2031-08-08
9694025 Merrem method of use 68 2031-08-08
10561675 Merrem method of use 68 2031-08-08
10183034 Merrem method of use 68 2031-08-08
7879828 Tygacil formulation 60 2029-02-05
8975242 Tygacil formulation 55 2028-10-24
8372995 Tygacil formulation 53 2030-10-08

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8680136 Merrem composition of matter 10 2031-08-29
12171772 Merrem composition of matter 23 2031-08-08
7531623 Vibativ composition of matter 27 2027-01-01
7531623 Vibativ composition of matter 27 2027-01-01
9855335 Tygacil formulation 42 2033-04-07
10172874 Merrem formulation 48 2031-08-08
8372995 Tygacil formulation 53 2030-10-08
8975242 Tygacil formulation 55 2028-10-24
7879828 Tygacil formulation 60 2029-02-05
10183034 Merrem method of use 68 2031-08-08

Related